Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Morphic Holding Inc
(NQ:
MORF
)
27.69
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
27.69
Bid (Size)
11.08 (2)
Ask (Size)
44.30 (2)
Prev. Close
27.69
Today's Range
27.69 - 27.69
52wk Range
19.34 - 62.08
Shares Outstanding
36,415,045
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
Today 7:00 EDT
From
Morphic Therapeutic
Via
GlobeNewswire
Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
April 02, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Performance
YTD
-4.29%
-4.29%
1 Month
-13.87%
-13.87%
3 Month
-2.02%
-2.02%
6 Month
+37.76%
+37.76%
1 Year
-40.71%
-40.71%
More News
Read More
Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
March 26, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Recap: Morphic Holding Q4 Earnings
February 22, 2024
Via
Benzinga
Where Morphic Holding Stands With Analysts
September 28, 2023
Via
Benzinga
MORF Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Morphic Holding, Inc. (NASDAQ:MORF)
March 20, 2024
From
Abraham, Fruchter & Twersky, LLP
Via
GlobeNewswire
Morphic Appoints Dr. Simon Cooper as Chief Medical Officer
March 19, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Morphic to Participate in March Investor Conferences
March 05, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
February 22, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors
January 11, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors
January 10, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors
January 04, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Robbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investors
December 01, 2023
From
Robbins LLP
Via
Business Wire
Morphic Holding, Inc. Reminder: Robbins LLP is Investigating MORF on Behalf of Investors
November 22, 2023
From
Robbins LLP
Via
Business Wire
Morphic to Present at November Investor Conferences
November 10, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023
November 03, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
NASDAQ: MORF Investor Notice: Investigation over Possible Securities Laws Violations by Morphic Holding, Inc.
November 01, 2023
Via
SBWire
Morphic Holding Investigation: Johnson Fistel Encourages Shareholders with Losses to Contact the Firm Regarding Investigation
October 21, 2023
From
Johnson Fistel, LLP
Via
Business Wire
Morphic Holding SHAREHOLDER ALERT: Johnson Fistel Encourages Morphic Holding Shareholders with Losses to Contact the Firm Regarding Investigation
October 14, 2023
From
Johnson Fistel, LLP
Via
Business Wire
Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set
October 09, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
MORF INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into Morphic Holding, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
September 29, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Stock Market Rally Attempt Underway; Micron, Nike, Amazon, Meta In Focus: Weekly Review
September 29, 2023
Via
Investor's Business Daily
Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence
September 26, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Gold Moves Lower; TransCode Therapeutics Shares Surge
September 25, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.